A new application of DNA testing, already used in a number of workers' health injury cases, has the potential to save insurers billions of dollars in defense costs, a scientist who pioneered the process said.
Dr. Bruce S. Gillis, chief executive officer of the Cytokine Institute in Los Angeles, said the trademarked technology--called "msds1" (otherwise known as Cytokine testing)--can ascertain if a person has had an injurious exposure to virtually any chemical or toxin and whether they experience pain from an injury.
The process has already been applied to two dozen workers' compensation cases in California, resulting in one settlement that the defense attorney on the case says has easily saved the insurer involved $1 million.
Recommended For You
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
